SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-193248
Filing Date
2021-06-17
Accepted
2021-06-17 16:37:41
Documents
12
Period of Report
2021-06-16
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d193508d8k.htm   iXBRL 8-K 28928
  Complete submission text file 0001193125-21-193248.txt   155877

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rna-20210616.xsd EX-101.SCH 3097
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rna-20210616_lab.xml EX-101.LAB 18888
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rna-20210616_pre.xml EX-101.PRE 11879
5 EXTRACTED XBRL INSTANCE DOCUMENT d193508d8k_htm.xml XML 3483
Mailing Address 10975 N. TORREY PINES RD., #150 LA JOLLA CA 92037
Business Address 10975 N. TORREY PINES RD., #150 LA JOLLA CA 92037 858-401-7900
Avidity Biosciences, Inc. (Filer) CIK: 0001599901 (see all company filings)

IRS No.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39321 | Film No.: 211025219
SIC: 2834 Pharmaceutical Preparations